Transaction Date | Recipient | Shares | Type | Price | Value |
---|---|---|---|---|---|
9th February 2021 | Michael J. Mc Elhaugh | 20,000 | Open or private sale | $5.00 | $100,000.00 |
14th December 2020 | Michael J. Mc Elhaugh | 30,000 | Open or private sale | $5.00 | $150,000.00 |
14th December 2020 | Michael J. Mc Elhaugh | 10,000 | Open or private sale | $5.00 | $50,032.00 |
23rd July 2020 | Michael J. Mc Elhaugh | 20,000 | Open or private sale | $5.01 | $100,200.00 |
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 5/10.
Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for chronic Hepatitis B virus infection. The company is headquartered in Burnaby, Canada.
25th February 2021
2nd February 2021